Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71


Relationship between Insurance Type at Diagnosis and Hepatocellular Carcinoma Survival.

Adler Jaffe S, Myers O, Meisner ALW, Wiggins CL, Hill DA, McDougall JA.

Cancer Epidemiol Biomarkers Prev. 2019 Dec 3. pii: cebp.0902.2019. doi: 10.1158/1055-9965.EPI-19-0902. [Epub ahead of print]


Correlates of poor adherence to a healthy lifestyle among a diverse group of colorectal cancer survivors.

Blair CK, McDougall JA, Chiu VK, Wiggins CL, Rajput A, Harding EM, Kinney AY.

Cancer Causes Control. 2019 Dec;30(12):1327-1339. doi: 10.1007/s10552-019-01241-8. Epub 2019 Oct 26.


Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics.

Blair CK, Wiggins CL, Nibbe AM, Storlie CB, Prossnitz ER, Royce M, Lomo LC, Hill DA.

NPJ Breast Cancer. 2019 Oct 2;5:33. doi: 10.1038/s41523-019-0128-4. eCollection 2019.


Disparities in Cancer Incidence and Trends among American Indians and Alaska Natives in the United States, 2010-2015.

Melkonian SC, Jim MA, Haverkamp D, Wiggins CL, McCollum J, White MC, Kaur JS, Espey DK.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1604-1611. doi: 10.1158/1055-9965.EPI-19-0288.


Cancer survivor perspectives on sharing patient-generated health data with central cancer registries.

Smith TG, Dunn ME, Levin KY, Tsakraklides SP, Mitchell SA, van de Poll-Franse LV, Ward KC, Wiggins CL, Wu XC, Hurlbert M, Aaronson NK.

Qual Life Res. 2019 Nov;28(11):2957-2967. doi: 10.1007/s11136-019-02263-0. Epub 2019 Aug 9.


Relationship between Diabetes and Diabetes Medications and Risk of Different Molecular Subtypes of Breast Cancer.

Chen H, Cook LS, Tang MC, Hill DA, Wiggins CL, Li CI.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1802-1808. doi: 10.1158/1055-9965.EPI-19-0291. Epub 2019 Aug 8.


Socioeconomic disparities in health-related quality of life among colorectal cancer survivors.

McDougall JA, Blair CK, Wiggins CL, Goodwin MB, Chiu VK, Rajput A, Kinney AY.

J Cancer Surviv. 2019 Jun;13(3):459-467. doi: 10.1007/s11764-019-00767-9. Epub 2019 May 20.


Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer.

Lorona NC, Cook LS, Tang MC, Hill DA, Wiggins CL, Li CI.

Horm Cancer. 2019 Jun;10(2-3):71-76. doi: 10.1007/s12672-019-00362-5. Epub 2019 Apr 15.


Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.

Kinney AY, Howell R, Ruckman R, McDougall JA, Boyce TW, Vicuña B, Lee JH, Guest DD, Rycroft R, Valverde PA, Gallegos KM, Meisner A, Wiggins CL, Stroup A, Paddock LE, Walters ST.

Contemp Clin Trials. 2018 Oct;73:123-135. doi: 10.1016/j.cct.2018.09.005. Epub 2018 Sep 18.


Incidence of primary liver cancer in American Indians and Alaska Natives, US, 1999-2009.

Melkonian SC, Jim MA, Reilley B, Erdrich J, Berkowitz Z, Wiggins CL, Haverkamp D, White MC.

Cancer Causes Control. 2018 Sep;29(9):833-844. doi: 10.1007/s10552-018-1059-3. Epub 2018 Jul 20.


Rural Disparities in Treatment-Related Financial Hardship and Adherence to Surveillance Colonoscopy in Diverse Colorectal Cancer Survivors.

McDougall JA, Banegas MP, Wiggins CL, Chiu VK, Rajput A, Kinney AY.

Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1275-1282. doi: 10.1158/1055-9965.EPI-17-1083. Epub 2018 Mar 28.


Cancer survival among Alaska Native people.

Nash SH, Meisner ALW, Zimpelman GL, Barry M, Wiggins CL.

Cancer. 2018 Jun 15;124(12):2570-2577. doi: 10.1002/cncr.31350. Epub 2018 Mar 26.


Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Jim MA, Pinheiro PS, Carreira H, Espey DK, Wiggins CL, Weir HK.

Cancer. 2017 Dec 15;123 Suppl 24:4994-5013. doi: 10.1002/cncr.30881.


Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women.

Chen L, Li CI, Tang MT, Porter P, Hill DA, Wiggins CL, Cook LS.

Cancer Epidemiol Biomarkers Prev. 2016 Sep;25(9):1297-304. doi: 10.1158/1055-9965.EPI-15-1104. Epub 2016 Jun 15.


Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.

Chen L, Cook LS, Tang MT, Porter PL, Hill DA, Wiggins CL, Li CI.

Breast Cancer Res Treat. 2016 Jun;157(3):545-54. doi: 10.1007/s10549-016-3825-9. Epub 2016 May 24.


Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012.

Hoffman RM, Meisner AL, Arap W, Barry M, Shah SK, Zeliadt SB, Wiggins CL.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):259-63. doi: 10.1158/1055-9965.EPI-15-0723. Epub 2015 Dec 8.


Effectiveness of the extended parallel process model in promoting colorectal cancer screening.

Birmingham WC, Hung M, Boonyasiriwat W, Kohlmann W, Walters ST, Burt RW, Stroup AM, Edwards SL, Schwartz MD, Lowery JT, Hill DA, Wiggins CL, Higginbotham JC, Tang P, Hon SD, Franklin JD, Vernon S, Kinney AY.

Psychooncology. 2015 Oct;24(10):1265-1278. doi: 10.1002/pon.3899. Epub 2015 Jul 20.


Efficacy of a Telehealth Intervention on Colonoscopy Uptake When Cost Is a Barrier: The Family CARE Cluster Randomized Controlled Trial.

Steffen LE, Boucher KM, Damron BH, Pappas LM, Walters ST, Flores KG, Boonyasiriwat W, Vernon SW, Stroup AM, Schwartz MD, Edwards SL, Kohlmann WK, Lowery JT, Wiggins CL, Hill DA, Higginbotham JC, Burt R, Simmons RG, Kinney AY.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1311-8. doi: 10.1158/1055-9965.EPI-15-0150. Epub 2015 Jun 22.


A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.

Guo Y, Kenney SR, Cook L, Adams SF, Rutledge T, Romero E, Oprea TI, Sklar LA, Bedrick E, Wiggins CL, Kang H, Lomo L, Muller CY, Wandinger-Ness A, Hudson LG.

Clin Cancer Res. 2015 Nov 15;21(22):5064-72. doi: 10.1158/1078-0432.CCR-15-0461. Epub 2015 Jun 12.


Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.

Harlan LC, Parsons HM, Wiggins CL, Stevens JL, Patt YZ.

Liver Cancer. 2015 Mar;4(1):70-83. doi: 10.1159/000367729.


Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States.

White MC, Espey DK, Swan J, Wiggins CL, Eheman C, Kaur JS.

Am J Public Health. 2014 Jun;104 Suppl 3:S377-87. doi: 10.2105/AJPH.2013.301673. Epub 2014 Apr 22.


Racial misclassification of American Indians and Alaska Natives by Indian Health Service Contract Health Service Delivery Area.

Jim MA, Arias E, Seneca DS, Hoopes MJ, Jim CC, Johnson NJ, Wiggins CL.

Am J Public Health. 2014 Jun;104 Suppl 3:S295-302. doi: 10.2105/AJPH.2014.301933. Epub 2014 Apr 22.


Colorectal cancer incidence and mortality disparities in new Mexico.

Hoffman RM, Espey DK, Rhyne RL, Gonzales M, Rajput A, Mishra SI, Stone SN, Wiggins CL.

J Cancer Epidemiol. 2014;2014:239619. doi: 10.1155/2014/239619. Epub 2014 Jan 2.


Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trial.

Kinney AY, Boonyasiriwat W, Walters ST, Pappas LM, Stroup AM, Schwartz MD, Edwards SL, Rogers A, Kohlmann WK, Boucher KM, Vernon SW, Simmons RG, Lowery JT, Flores K, Wiggins CL, Hill DA, Burt RW, Williams MS, Higginbotham JC.

J Clin Oncol. 2014 Mar 1;32(7):654-62. doi: 10.1200/JCO.2013.51.6765. Epub 2014 Jan 21.


Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial.

Simmons RG, Lee YC, Stroup AM, Edwards SL, Rogers A, Johnson C, Wiggins CL, Hill DA, Cress RD, Lowery J, Walters ST, Jasperson K, Higginbotham JC, Williams MS, Burt RW, Schwartz MD, Kinney AY.

Trials. 2013 Apr 30;14:116. doi: 10.1186/1745-6215-14-116.


Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites.

Cook LS, Nelson HE, Cockburn M, Olson SH, Muller CY, Wiggins CL.

Cancer Causes Control. 2013 Jan;24(1):61-9. doi: 10.1007/s10552-012-0090-z. Epub 2012 Oct 30.


Diversification and trends in biliary tree cancer among the three major ethnic groups in the state of New Mexico.

Nir I, Wiggins CL, Morris K, Rajput A.

Am J Surg. 2012 Mar;203(3):361-5; discussion 365. doi: 10.1016/j.amjsurg.2011.12.002. Epub 2012 Jan 10.


Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006.

Jemal A, Saraiya M, Patel P, Cherala SS, Barnholtz-Sloan J, Kim J, Wiggins CL, Wingo PA.

J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S17-25.e1-3. doi: 10.1016/j.jaad.2011.04.032.


Reuniting public health and medicine: the University of New Mexico School of Medicine Public Health Certificate.

Geppert CM, Arndell CL, Clithero A, Dow-Velarde LA, Eldredge JD, Kalishman S, Kaufman A, McGrew MC, Snyder TM, Solan BG, Timm CT, Tollestrup K, Wagner LK, Wiese WH, Wiggins CL, Cosgrove EM.

Am J Prev Med. 2011 Oct;41(4 Suppl 3):S214-9. doi: 10.1016/j.amepre.2011.06.001. Erratum in: Am J Prev Med. 2012 Jul;43(1):123. Eldredge, Jonathan P [corrected to Eldredge, Jonathan D].


Method of detection and breast cancer survival disparities in Hispanic women.

Hill DA, Nibbe A, Royce ME, Wallace AM, Kang H, Wiggins CL, Rosenberg RD.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2453-60. doi: 10.1158/1055-9965.EPI-10-0164. Epub 2010 Sep 14.


Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia.

Wiggins CL, Harlan LC, Nelson HE, Stevens JL, Willman CL, Libby EN, Hromas RA.

Am J Med. 2010 Aug;123(8):764.e1-9. doi: 10.1016/j.amjmed.2010.03.018.


Reproductive outcomes in male childhood cancer survivors: a linked cancer-birth registry analysis.

Chow EJ, Kamineni A, Daling JR, Fraser A, Wiggins CL, Mineau GP, Hamre MR, Severson RK, Drews-Botsch C, Mueller BA.

Arch Pediatr Adolesc Med. 2009 Oct;163(10):887-94. doi: 10.1001/archpediatrics.2009.111.


Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis.

Mueller BA, Chow EJ, Kamineni A, Daling JR, Fraser A, Wiggins CL, Mineau GP, Hamre MR, Severson RK, Drews-Botsch C.

Arch Pediatr Adolesc Med. 2009 Oct;163(10):879-86. doi: 10.1001/archpediatrics.2009.112.


Changing pattern of esophageal cancer incidence in New Mexico: a 30-year evaluation.

Vega KJ, Jamal MM, Wiggins CL.

Dig Dis Sci. 2010 Jun;55(6):1622-6. doi: 10.1007/s10620-009-0918-x. Epub 2009 Aug 18.


Cervical cancer incidence in the United States in the US-Mexico border region, 1998-2003.

Coughlin SS, Richards TB, Nasseri K, Weiss NS, Wiggins CL, Saraiya M, Stinchcomb DG, Vensor VM, Nielson CM.

Cancer. 2008 Nov 15;113(10 Suppl):2964-73. doi: 10.1002/cncr.23748.


Gastric cancer among American Indians and Alaska Natives in the United States, 1999-2004.

Wiggins CL, Perdue DG, Henderson JA, Bruce MG, Lanier AP, Kelley JJ, Seals BF, Espey DK.

Cancer. 2008 Sep 1;113(5 Suppl):1225-33. doi: 10.1002/cncr.23732.


Cancer among American Indians and Alaska Natives in the United States, 1999-2004.

Wiggins CL, Espey DK, Wingo PA, Kaur JS, Wilson RT, Swan J, Miller BA, Jim MA, Kelly JJ, Lanier AP.

Cancer. 2008 Sep 1;113(5 Suppl):1142-52. doi: 10.1002/cncr.23734.


Methods for improving cancer surveillance data in American Indian and Alaska Native populations.

Espey DK, Wiggins CL, Jim MA, Miller BA, Johnson CJ, Becker TM.

Cancer. 2008 Sep 1;113(5 Suppl):1120-30. doi: 10.1002/cncr.23724.


Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.

Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE.

Arch Dermatol. 2008 Apr;144(4):515-21. doi: 10.1001/archderm.144.4.515.


Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program.

Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE.

J Invest Dermatol. 2008 May;128(5):1340-2. doi: 10.1038/jid.2008.18. No abstract available.


Epidemiologic support for melanoma heterogeneity using the Surveillance, Epidemiology, and End Results Program.

Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE.

J Invest Dermatol. 2008 Jan;128(1):243-5. Epub 2007 Aug 23. No abstract available. Corrected and republished in: J Invest Dermatol. 2008 May;128(5):1340-2.


Differences in cancer incidence among Indians in Alaska and New Mexico and U.S. Whites, 1993-2002.

Kelly JJ, Lanier AP, Alberts S, Wiggins CL.

Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1515-9.


Malignant melanoma in pregnancy.

Wiggins CL, Berwick M, Bishop JA.

Obstet Gynecol Clin North Am. 2005 Dec;32(4):559-68. Review.


Toward a better understanding of the comparatively high prostate cancer incidence rates in Utah.

Merrill RM, Hilton SC, Wiggins CL, Sturgeon JD.

BMC Cancer. 2003 Apr 29;3:14.


Ethnic differences at risk for gestational trophoblastic disease in New Mexico: A 25-year population-based study.

Smith HO, Hilgers RD, Bedrick EJ, Qualls CR, Wiggins CL, Rayburn WF, Waxman AG, Stephens ND, Cole LW, Swanson M, Key CR.

Am J Obstet Gynecol. 2003 Feb;188(2):357-66.


Diminished survival in patients with inner versus outer quadrant breast cancers.

Gaffney DK, Tsodikov A, Wiggins CL.

J Clin Oncol. 2003 Feb 1;21(3):467-72.


A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?

Carney ME, Lancaster JM, Ford C, Tsodikov A, Wiggins CL.

Gynecol Oncol. 2002 Jan;84(1):36-42.


Native American Cancer Conference III. Cognitive correlates and impressions of attendees.

Mahoney MC, Michalek AM, Wiggins CL, Tenney M, Bad Wound D, Burhansstipanov L.

Cancer. 1996 Oct 1;78(7 Suppl):1533-7.


Supplemental Content

Loading ...
Support Center